DURVALUMAB
Clinical trials for DURVALUMAB explained in plain language.
Never miss a new study
Get alerted when new DURVALUMAB trials appear
Sign up with your email to follow new studies for DURVALUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Precision radiation teams up with immune drugs in fight against tough liver cancers
Disease control Recruiting nowThis study is testing a combination treatment for liver cancer that cannot be removed by surgery. It combines precise proton radiation therapy with two immunotherapy drugs (tremelimumab and durvalumab) that help the body's immune system fight the cancer. The goal is to see if thi…
Matched conditions: DURVALUMAB
Phase: PHASE2 • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New hope for tough liver cancer: triple attack trial
Disease control Recruiting nowThis study is testing whether a three-part treatment can better control advanced bile duct cancer that starts in the liver. Researchers will give chemotherapy directly to the liver through an artery, combined with two drugs that work throughout the body. The trial aims to see if …
Matched conditions: DURVALUMAB
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC